Elyxium Wealth’s Vaxcyte PCVX Stock Holding History

Elyxium Wealth’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$9.33K	Buy	+164	New	+$9.6K	﹤0.01%	1038

Other funds holding PCVX

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $53.6B AUM 32.29% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

BG Investment Services Hagatna, Guam $673M AUM 14.41% 1-Year Est. Return

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return

Elyxium Wealth's PCVX Position: Q3 2026 in Review

Elyxium Wealth opened a new position in Vaxcyte (PCVX) in Q3 2026: 164 shares worth $9.33K. The stake represents ﹤0.01% of the portfolio and ranks #1038 among its holdings.

65 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.

Elyxium Wealth held 164 shares of Vaxcyte worth $9.33K as of Q3 2026.
Vaxcyte was a new Elyxium Wealth position in Q3 2026.
Vaxcyte made up ﹤0.01% of Elyxium Wealth's portfolio in Q3 2026, its #1038 holding.
65 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.

Based on Elyxium Wealth's 13F filing for Q3 2026, filed 27 Oct 2026.